Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
Manolo D’Arcangelo,1,2 Federico Cappuzzo2 1Cancer Center, University of Colorado, Aurora (CO), USA; 2Department of Oncology, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy Abstract: Lung cancer treatment has rapidly changed in the last few years thanks to novel insights into...
Guardado en:
Autores principales: | D'Arcangelo M, Cappuzzo F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b23c5be47f34ac981950e6910814146 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical and comparative utility of afatinib in non-small cell lung cancer
por: D'Arcangelo M, et al.
Publicado: (2014) -
Profile of bavituximab and its potential in the treatment of non-small-cell lung cancer
por: Stasi I, et al.
Publicado: (2014) -
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
por: William Boland, et al.
Publicado: (2010) -
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Chad A Reade, et al.
Publicado: (2009) -
Non-small cell lung cancer: the era of targeted therapy
por: Antonoff MB, et al.
Publicado: (2012)